[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.196.37. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 11, 1978

Levodopa Therapy and Malignant Melanoma

Author Affiliations

From the Department of Dermatology, Massachusetts General Hospital and Harvard Medical School (Drs Sober and Wick), and Sidney Farber Cancer Center (Dr Wick), Boston.

JAMA. 1978;240(6):554-555. doi:10.1001/jama.1978.03290060056015
Abstract

Concern has been voiced over a role for levodopa in the induction or stimulation of growth of cutaneous malignant melanoma. Prospective query of 1,099 patients of the Melanoma Clinical Cooperative Group at the time of presentation of their primary melanoma showed only one patient who had been taking levodopa. It was concluded that levodopa, if a factor in the induction of melanoma, must be playing an inconsequential role in the rapid rise in incidence observed for this tumor over the past decade.

(JAMA 240:554-555, 1978)

×